Low or no data? Visit zero.govt.nz, scroll down the page then click on our logo to return to our site and browse for free.

Immune checkpoint inhibitor topics

Immune checkpoint inhibitors are a new immunotherapy treatment option for advanced non–small-cell lung cancer (NSCLC). Learn more about immune checkpoint inhibitors.

Immune checkpoint inhibitors for advanced non–small-cell lung cancer

Keytruda (also called pembrolizumab)

Tecentriq (also called atezolizumab)

Imfinzi (also called durvalumab)